Antidepressants are typically one of the most costly drug classes in the drug budget. Due to the higher costs of many of the newer antidepressants, a number of studies have been conducted to evaluate the clinical and cost aspects of depression treatment. The purpose of this month's Practical Pharmacoeconomics column is to assist readers in interpreting a cost- effectiveness evaluation of antidepressant drugs that used a decision tree model to assess the treatment of major depression.
|Original language||English (US)|
|Number of pages||5|
|Publication status||Published - Aug 1999|
ASJC Scopus subject areas
- Pharmaceutical Science